ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Ultragenyx Pharmaceutical Inc

Ultragenyx Pharmaceutical Inc (UP0)

40.40
0.20
(0.50%)
Closed January 05 4:00PM
Realtime Data

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
40.40
Bid
40.00
Ask
40.20
Volume
20
40.20 Day's Range 40.20
34.80 52 Week Range 54.00
Previous Close
40.20
Open
40.20
Last Trade
20
@
40.2
Last Trade Time
Average Volume (3m)
126
Financial Volume
-
VWAP
-

UP0 Latest News

NHS England Rolls Out Evkeeza® ▼(evinacumab) for Eligible Adults and Adolescents Aged 12 Years and Older with Homozygous Familial Hypercholesterolaemia (HoFH)

NHS England Rolls Out Evkeeza® ▼(evinacumab) for Eligible Adults and Adolescents Aged 12 Years and Older with Homozygous Familial Hypercholesterolaemia (HoFH) LONDON, Dec. 20, 2024 (GLOBE...

Ultragenyx presenta Evkeeza® (concentrado de evinacumab para solución para infusión) en España para el tratamiento de la hipercolesterolemia familiar homocigótica (HFho)

Ultragenyx presenta Evkeeza® (concentrado de evinacumab para solución para infusión) en España para el tratamiento de la hipercolesterolemia familiar homocigótica (HFho) Evkeeza es un medicamento...

Ultragenyx Receives Positive Recommendation from NICE in the U.K. for Evkeeza® ▼ (evinacumab) for Adolescents and Adults Aged 12 Years and Older with Homozygous Familial Hypercholesterolemia (HoFH)

Ultragenyx Receives Positive Recommendation from NICE in the U.K. for Evkeeza® ▼ (evinacumab) for Adolescents and Adults Aged 12 Years and Older with Homozygous Familial Hypercholesterolemia...

Ultragenyx Receives European Commission Decision for Evkeeza® (evinacumab) Expanded Indication in Children Aged 5 Years and Older with Homozygous Familial Hypercholesterolemia (HoFH)

Ultragenyx Receives European Commission Decision for Evkeeza® (evinacumab) Expanded Indication in Children Aged 5 Years and Older with Homozygous Familial Hypercholesterolemia (HoFH) For the...

Ultragenyx lancia in Italia Evkeeza® (evinacumab concentrato in soluzione per infusione) per il trattamento dell’ipercolesterolemia familiare omozigote (HoFH)

Ultragenyx lancia in Italia Evkeeza® (evinacumab concentrato in soluzione per infusione) per il trattamento dell’ipercolesterolemia familiare omozigote (HoFH) Evkeeza è un farmaco, primo nel...

Zur Behandlung der homozygoten familiären Hypercholesterinämie (HoFH): Ultragenyx führt Evkeeza® (Evinacumab) in Deutschland ein

Zur Behandlung der homozygoten familiären Hypercholesterinämie (HoFH): Ultragenyx führt Evkeeza® (Evinacumab) in Deutschland ein Evkeeza® ist das erste von der U.S. Food and Drug...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.6-3.809523809524242.240.220641.29294404DE
4-4.2-9.4170403587444.646.440.226142.0995687DE
12-10.1-2050.553.540.212644.27703085DE
262.87.4468085106437.65437.215145.38101378DE
52-2.6-6.04651162791435434.79999916942.96720088DE
1561.84.6632124352338.65430.616441.72689478DE
2601.84.6632124352338.65430.616441.72689478DE

UP0 - Frequently Asked Questions (FAQ)

What is the current Ultragenyx Pharmaceutical share price?
The current share price of Ultragenyx Pharmaceutical is 40.40 €
What is the 1 year trading range for Ultragenyx Pharmaceutical share price?
Ultragenyx Pharmaceutical has traded in the range of 34.80 € to 54.00 € during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
0S6Cerence Inc
18.972 €
(145.34%)
90.04k
CY9DMicrobot Medical Inc
2.11 €
(89.07%)
24.21k
RV0Torrent Gold Inc
0.138 €
(73.58%)
1.23k
7CCCheckCap Ltd
1.76 €
(55.75%)
6.55k
34Q0Quantum eMotion Inc
0.985 €
(53.91%)
1.62M
FASFastenal Co
9.7358 €
(-85.95%)
2.13k
1UR1Bee Vectoring Technologies International Inc
0.003 €
(-45.45%)
300.18k
B4T0CuFe Ltd
0.0045 €
(-25.00%)
1
H5EHelma Eigenheimbau Ag
0.0766 €
(-23.40%)
751
2WOWide Open Agriculture Ltd
0.005 €
(-23.08%)
50k
PF8European Lithium Limited
0.0264 €
(8.20%)
5.76M
3CPXiaomi Corporation
4.597 €
(7.34%)
3.95M
D7GNel ASA
0.247 €
(2.66%)
2.33M
J9AVERSES AI Inc
1.352 €
(0.00%)
1.67M
34Q0Quantum eMotion Inc
0.985 €
(53.91%)
1.62M

Discussion

View Full Feed
NeoSunTzu NeoSunTzu 5 minutes ago
It becomes EXREMELY TIRESOME to fully detail EVERY SINGLE DAMN POINT about this story which has a million data points to speak of. My point is they will HIGHLY LIKELY NOT get put back on the NYSE while under c'ship UNLESS our boys want to make an explicit point. Additionally, trading on the NYSE und
zerosnoop zerosnoop 5 minutes ago
Lets see if any of these paid bashers, naked shorters or compulsive liar's bother to show up at the shareholders meeting in February to ask any questions. Common sense tells me these uneducated fools with a low IQ, cowards, grubs & keyboard warriors will stay hiding in their basement hah hah hah
QSEP
236T568 236T568 6 minutes ago
Yikes
https://x.com/visegrad24/status/1876118192168599586?s=19
3331 3331 6 minutes ago
I have Staelin penned as a masterful business strategist. He MUST have a plan.
GetSeriousOK, post #
BIEL
Loudanepro Loudanepro 6 minutes ago
Here are some of them; I’m sure you’ll recognize some of the aliases

https://www.sec.gov/newsroom/press-releases/2022-221
TTCM
Merv77 Merv77 6 minutes ago
fFIE Looks like a short squeeze happening soon ? 
joyceschoice joyceschoice 7 minutes ago
Good point. Let's see if the mods delete this post.
LEHNQ
Merv77 Merv77 7 minutes ago
FFIR stock to look at 
marcis marcis 8 minutes ago
Dude they voted to have the 2024 fins buy the end of April

You make a bogus claim

And the SEC had it’s audit guidelines changed just on Dec15

Next
RDAR
MartinLutherKing MartinLutherKing 10 minutes ago
Do you think the CEo fitzgerald and all his nobel lab rats in management are pocketed investors money while they sabotage the cure to cancer
timberwolf7 timberwolf7 10 minutes ago
TNXP presentation dated 2 Jan 2025. Slide 45 has a 'timeline' listing...

https://d1io3yog0oux5.cloudfront.net/_d620cad351857eb785bc6984eeac7786/tonixpharma/db/211/4414/pdf/Tonix+Short+Investor+Presentation+01.02.25+v1.pdf
TNXP
nowwhat2 nowwhat2 11 minutes ago
WHY SO HARD DROP RIGHT BACK DOWN ?........

https://investorshub.advfn.com/uimage/uploads/2025/1/5/ckgzmtotal_!_5_CAPT_7pm_XRP_RESIST.jpg




https://investorshub.advfn.com/uimage/uploads/2025/1/5/ouvwitotal_!_5_3m_7pm_RESIST.jpg

4Leaf 4Leaf 11 minutes ago
Hey guys. I found this link on Amazon. Crazy that you can't buy now. Hmm. One has to wonder how can Amazon do thiis, meaning how can they offer a product on their platform that no one can buy. Maybe they are still updating the listing. SMH. Yall know what's up. Any insight on this? Link below. 
AITX
Monroe1 Monroe1 11 minutes ago
Wish we were in the running here. With all the knife throwing going on lately, we should at least make them!!

Consumer Automotive Finance Subsidiary Drago Knives Narrows Down Potential Partner to Manufacture Patented Throwing Knives
December 20 2024 - 9:00AM
InvestorsHu
CAFI
MartinLutherKing MartinLutherKing 12 minutes ago
What if they get green light for fast track status
zerosnoop zerosnoop 12 minutes ago
YES. The latest news release clearly states "CONTRACTS have been issued". This must mean waiting for sign offs. The PROVEN AOT is going GLOBAL. Tic toc tic toc.

Expansion into Global Markets

Over the past year, QS Energy has made notable strides in deploying its Applied
QSEP
NeoSunTzu NeoSunTzu 17 minutes ago
I would like to caution and implore everyone to be as proactive and vocal as possible in fighting against the full execution of the warrants. Everyone is giddy and light-headed now with all the rosy financial scenarios and the fact that we have an ostensibly "pro-shareholder" team coming into office
FNMA
Rocky3 Rocky3 17 minutes ago
Let's all admit the truth that Enta made some real bad decisions and then caught a real bad break.

In my view, the worst break was the pricing decision by ABBV in HCV. The market was cut significantly by the decision to compete on price. It killed the receipts for both ABBV and GILD
ABBV
renaissance1 renaissance1 17 minutes ago
Can you post the link to the Instagram post by chance? If not no worries. TIA. HAPPY NEW YEAR TO YOU AS WELL.
GIFX
HoldEm777 HoldEm777 19 minutes ago
This isn’t audited and doubt seriously it ever will be. What about that low interest line of credit? I have yet to hear about it. Thanks
RDAR
Top Penny Top Penny 21 minutes ago
Kim Halvorson Owner of more than 5% Marysville,
Washington
800,000,000 Common 5.3%
PSRU
Shawonsarker84 Shawonsarker84 21 minutes ago
I think the market will push it this week. I noticed 5.7B restricted hasn't changed since Dec 27th. LFG

The Best Part of the New #HMBL
is that it's NOT $HMBL.

$TSNP 1.0

$TSNP 2.0 -> $HMBL

$TSNP 3.0 -> $FinCapital

One
FINCAPITAL HMBL SMX
nowwhat2 nowwhat2 21 minutes ago
WHY SO HARD DROP RIGHT BACK DOWN ?........

https://investorshub.advfn.com/uimage/uploads/2025/1/5/ckgzmtotal_!_5_CAPT_7pm_XRP_RESIST.jpg




https://investorshub.advfn.com/uimage/uploads/2025/1/5/ouvwitotal_!_5_3m_7pm_RESIST.jpg

BTCUSD
New money98 New money98 22 minutes ago
Great..Now provide the agreements that were reached between the secured creditors and Visolis...
marcis marcis 22 minutes ago
No
Do your own research
RDAR

Your Recent History

Delayed Upgrade Clock